High expression of the RECK gene in breast cancer cells is related to low invasive capacity

Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. Int J Cancer. 2002,99:157–166.

Benaud C, Dickson RB, Thompson EW. Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res Treat. 1998;50:97–116.

Duffy MJ, Maguire TM, Hill A, et al. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000;2:252–257.

Toshihiko M, Ryuichiro D, Takatomo K, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clinical Cancer Res. 2003;9:1779–1784.

Eisenberg H, Hochner M, Sadeh Z, et al. Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene. Gene Mapping, Cloning and Sequencing. 2002;97:58–61.

Takahashi C, Sheng Z, Horan TP et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA. 1998;95:13221–13226.

Oh J, Takahashi R, Kondo S et al. The membrane-ahchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001;107:789–800.

Furumoto K, Arii S, Mori A et al. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinopathological factors and its clinical significance. Hepatology 2001;33:189–195.